Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shanghai Wibson Biotechnology WBS

Shanghai Wibson Biotechnology WBS

Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shanghai Wibson Biotechnology WBS between 19 Jan 2026 and 23 Apr 2026. Test scores average over 7, no score below 6, and at least 6 tests warrant a confident Finnrick Rating of A (Great).

Finnrick Rating™
Shanghai Wibson Biotechnology WBS
Retatrutide
Tested 6 Samples
Last test 23 Apr 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Shanghai Wibson Biotechnology WBS

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.7MIN6.5MAX9.3

Last

23 Apr 2026

First

19 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
23 Apr 2026View9.310mg10.7mg+7.0%99.90%510002White Label / Silver Crimp / White CapLab EPublic
6 Mar 2026View6.630mg29.9mg-0.3%99.30%(no batch ID)No Label / Silver Crimp / Violet CapLab EPublic
2 Mar 2026View8.010mg10.4mg+4.0%99.90%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
20 Feb 2026View8.510mg10.8mg+8.0%99.70%510002No Label / Silver Crimp / White CapLab GPublic
22 Jan 2026View6.510mg10.9mg+9.0%99.80%(no batch ID)White Label / Silver Crimp / White CapLab GPublic
19 Jan 2026View7.230mg27.8mg-7.3%99.95%(no batch ID)Green Label / Silver Crimp / Violet CapLab EPublic